Editas Medicine

Editas Medicine

Employees:
100
Market Cap:
$1.38 billion
Revenue:
$13.87 million
Net Income:
$-112.6 million

Editas Medicine is a discovery-phase pharmaceutical company based in Cambridge, Massachusetts which aims to develop therapies based on CRISPR–Cas9 gene editing technology. The company went public on 2 Feb 2016. Wikipedia

Editas Medicine

Editas Medicine is a discovery-phase pharmaceutical company based in Cambridge, Massachusetts which aims to develop therapies based on CRISPR–Cas9 gene editing technology. The company went public on 2 Feb 2016. Wikipedia

Employees:
100
Market Cap:
$1.38 billion
Revenue:
$13.87 million
Net Income:
$-112.6 million

14 jobs at Editas Medicine

Jobs in